According to Newsweek, although no official confirmation from China came the data shows, “30.2 percent of tests coming back positive for it—an increase of 6.2 from the previous week—and 17.7 percent of people hospitalized with a severe respiratory illness testing positive for it.”

The Week Magazine remarked, “Five years post-Covid-19, China grapples with new 'Human Metapneumovirus' threat.”

HMVP is not new, it was discovered first in 2001.

According to the Centers for USA government public health agency, CDC, “Human metapneumovirus (HMPV) can cause upper and lower respiratory disease in people of all ages, especially among young children, older adults, and people with weakened immune systems. Discovered in 2001, HMPV is in the Pneumoviridae family along with respiratory syncytial virus (RSV). Broader use of molecular diagnostic testing has increased identification and awareness of HMPV as an important cause of upper and lower respiratory infection.”

“Symptoms commonly associated with HMPV include cough, fever, nasal congestion, and shortness of breath. Clinical symptoms of HMPV infection may progress to bronchitis or pneumonia and are similar to other viruses that cause upper and lower respiratory infections. The estimated incubation period is 3 to 6 days, and the median duration of illness can vary depending upon severity but is similar to other respiratory infections caused by viruses,” says CDC.